5.50 CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Exhibits CLL Antitumor Activity

✍ Scribed by Renee Prins; Luke B. Fletcher; Russell T. Burke; Marc M. Loriaux; Brian J. Druker; Stephen E. Spurgeon

• Book ID: 119218994
• Publisher: Elsevier
• Year: 2011
• Tongue: English
• Weight: 97 KB
• Volume: 11
• Category: Article
• ISSN: 2152-2650
• DOI: 10.1016/j.clml.2011.09.204